Quanterix (QTRX) EBITDA Margin Growth (3y) (2020 - 2026)
Quanterix (QTRX) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 244.00 |
| 10 | Quanterix | 150.23 Mn | 56.70 Mn | 12.67 Mn | -12,104.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12,104.00 |
| Mar 31, 2026 | -7,641.00 |
| Dec 31, 2025 | 2,640.00 |
| Sep 30, 2025 | 4,967.00 |
| Jun 30, 2025 | -3,684.00 |
| Mar 31, 2025 | -2,617.00 |
| Dec 31, 2024 | 1,687.00 |
| Sep 30, 2024 | 2,221.00 |
| Jun 30, 2024 | 2,205.00 |
| Mar 31, 2024 | -1,129.00 |
| Dec 31, 2023 | -515.00 |
| Sep 30, 2023 | -4,784.00 |
| Jun 30, 2023 | 6,375.00 |
| Mar 31, 2023 | 3,740.00 |
| Dec 31, 2022 | -1,068.00 |
| Sep 30, 2022 | -7,390.00 |
| Jun 30, 2022 | -3,706.00 |
| Mar 31, 2022 | 1,509.00 |
| Dec 31, 2021 | 2,768.00 |
| Sep 30, 2021 | 1,733.00 |